NFCR Global Summit and Award Ceremonies
For Cancer Research & Entrepreneurship
Friday, October 18, 2024
Co-Hosted by
A Cutting-edge Cancer Research Conference Featuring Leading Cancer Scientists, Entrepreneurs, Investors, Business Leaders, & Advocates.
Sponsorship Opportunities
Inquiries regarding sponsorship of our Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship event can be made to Executive Director, Brian Wachtel by e-mail at Bwachtel@nfcr.org or by phone at 1-800-321-CURE (2873). Learn more in our sponsorship packet.
8:45 AM: Part I: New Frontiers for Cancer Research (Sessions: New Approaches to Cancer Treatments, Early Detection & Cancer Prevention)
12:30 PM: Part II: Luncheon & AIM-HI Women’s Initiatives Award Ceremony
1:30 PM: Part III: Investors’ Perspectives for Early-Stage Companies
4:00 – 6:00 PM: Intermission
6:00 PM: Part IV: Reception, Dinner & Szent-Györgyi Prize Award Ceremony
American Association for Cancer Research
2024 Beacon Award for Women Leaders in Oncology Winner
Dennis J. Slamon, M.D., Ph. D.
UCLA Health
2024 Szent-Györgyi Prize for Progress in Cancer Research Winner
Drew Pardoll, MD., Ph.D.
Director, Bloomberg- Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine
Siddhartha Mukherjee, M.D.
2011 Pulitzer Prize Winner, Associate Professor of Medicine, Columbia University Irving Medical Center, Columbia University
FULL EVENT DETAILS
Part I: New Frontiers for Cancer Research
8:45 AM – 9:00 AM:
Welcome Remarks:
Dr. Sujuan Ba CEO of NFCR and Co-Founder of AIM-HI Accelerator Fund
Dr. Web Cavenee Chair of the Scientific Advisor Board of NFCR and UCSD Distinguished Professor
9:00 AM – 9:30 AM:
9:30 AM – 10:30 AM:
Keynote Presentation:
Drew Pardoll, MD., Ph.D. Director, Bloomberg- Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine
Session I: New Approaches to Cancer Treatments
Moderator: Lisa Coussens, Ph.D., Oregon Health & Science University
Panelists:
Aditya Bardia, M.D., University of California, Los Angeles
Jonathan Chernoff, M.D., Ph.D., Fox Chase Cancer Center
Paul Mischel, M.D., Stanford University
Scott Lippman, M.D., University of California, San Diego
10:30 AM – 11:00 AM:
Coffee Break
11:00 AM – 12:00 PM:
Session II: Early Detection & Cancer Prevention
Moderator: Carlos Doti, M.D., AstraZeneca VP, Head of Oncology, US Medical Affairs
Panelists:
Ajay Goel, Ph.D., Beckman Research Institute of City of Hope
Samir Hanash, M.D., Ph.D., MD Anderson Cancer Center
Steven Lipkin, M.D., Ph.D., Weill Cornell Medicine
Sapna Syngal, M.D., MPH, Dana-Farber Cancer Institute
12:00 PM – 12:30 PM:
Break and Lunch
Part II: Luncheon Award Ceremony
12:30 PM – 12:55 PM:
AIM-HI Beacon Award Ceremony Honoring Margaret Foti, Ph.D., M.D. (hc)
Introduction of the 2024 Beacon Award Recipient by Sujuan Ba, Co-Chair of 2024 Beacon Award Selection Committee
Presenting the Beacon Award Medallion to the Recipient by the Award Selection Committee Members
2024 AIM-HI Beacon Award Winner Presentation
Margaret Foti, Ph.D., M.D. (hc), CEO, American Association for Cancer Research
12:55 PM – 1:20 PM:
AIM-HI Women’s Venture Competition Award Ceremony
2024 AIM-HI Women’s Venture Competition Winners Award Presentations
First Prize with Distinction
Nabanita Nawar, Ph.D.
Co-Founder & CEO, HDAX Therapeutics
Second Prize
Paraskevi Giannakakou, Ph.D.
Co-Founder & CSO, ARMA Bio
1:20 PM – 1:30 PM:
Coffee Break
Part III: Innovative Oncology Company Showcase and Investors’ Perspective
1:30 PM – 3:00 PM:
Welcome Remarks by Matt Tremblay, Ph.D., Chairman of the Board of AIM-HI Accelerator Fund and CEO of Blackbird Laboratories and Blackbird BioVentures
Session I: Innovative Oncology Companies Showcase:
Jenny Lesser Herbach, MBA, CEO Adventris
Ronald Herbst, Ph.D., CMO Biolojic Design
Vipin Suri, Ph.D., CMO Clasp Therapeutics
Lily Zou, Ph.D., MBA, CEO Degron Therapeutics
Samir Khleif, M.D., CEO Georgiamune
3:00 PM– 3:10 PM:
Coffee Break
3:10 PM – 4:10 PM:
Session II: Investor’s Perspectives for Early-Stage Oncology Companies
Moderator: Matt Tremblay
Panelists:
Dave Greenwald, Ph.D. Vice President Business Development of Deerfield and CEO, Aviko Radiopharmaceuticals
Beverly Lu, Ph.D. Investor, Yosemite
Marie-Claire Peakman, Ph.D. Pfizer Ventures
Fei Shen, Ph.D. Managing Director, BI Venture Fund
4:10 PM – 6:00 PM:
Intermission Break
Part IV: Dinner Award Ceremony
Honoring Dennis J. Slamon, M.D., Ph.D. (Black-tie Optional)
6:00 PM – 7:00 PM:
7:00 PM – 7:30 PM:
7:30 PM – 8:55 PM:
Cocktail Reception
Emcee: Kristen Berset-Harris, Host of Great Day Washington, WUSA9
Opening Remarks by Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI & Founder of AFCR, Co-Chair of 2024 Szent-Györgyi Prize Selection Committee
Introduction of Keynote Speaker by Azra Raza, M.D., Chan Soon-Shiong Professor of Medicine, Columbia University in New York
Keynote Speaker – Siddhartha Mukherjee, M.D., 2011 Pulitzer Prize Winner, Associate Professor of Medicine, Columbia University Irving Medical Center, Columbia University
Introduction of 2023 Szent-Györgyi Prize Winner: Isaac Witz, Ph.D., Professor Emeritus at Tel Aviv University
Presentation of the 2024 Szent-Györgyi Prize Winner Dennis J. Slamon, M.D., Ph.D., Professor of Medicine, Director of Clinical and Translational Research, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA
Panel Discussion Live from Press Club:
Panelists: Dennis Slamon, Margaret Foti, Siddhartha Mukherjee, Funmi Olopade, Mohit Manrao, and Shereen and Isabella Pavlides (cancer research advocates)
8:55 PM:
Closing Remarks by Dr. Alfred Slanetz, Chairman of NFCR